A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
Phase of Trial: Phase II
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Tivozanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Jul 2018 Status changed from active, no longer recruiting to completed.
- 28 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.